Okomera Revenue and Competitors
Estimated Revenue & Valuation
- Okomera's estimated annual revenue is currently $5.1M per year.
- Okomera's estimated revenue per employee is $155,000
- Okomera's total funding is $11M.
Employee Data
- Okomera has 33 Employees.
- Okomera grew their employee count by 3% last year.
Okomera's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Product Development | Reveal Email/Phone |
3 | Manager industrialialisation | Reveal Email/Phone |
4 | Biotech Engineer | Reveal Email/Phone |
5 | Formulation Scientist | Reveal Email/Phone |
6 | Ingénieur Bio-Application | Reveal Email/Phone |
Okomera Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4M | 26 | -30% | N/A | N/A |
#2 | $5.9M | 38 | 9% | N/A | N/A |
#3 | $3.4M | 22 | 0% | N/A | N/A |
#4 | $1.2M | 15 | -62% | €100.3M | N/A |
#5 | $14.7M | 95 | 1% | $121M | N/A |
#6 | $3.3M | 21 | -19% | N/A | N/A |
#7 | $10.1M | 65 | 18% | N/A | N/A |
#8 | $4.2M | 27 | 17% | $6.56M | N/A |
#9 | $6.7M | 43 | 10% | N/A | N/A |
#10 | $4M | 26 | -33% | N/A | N/A |
What Is Okomera?
We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity
keywords:N/A$11M
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 33 | -17% | N/A |
#2 | $3.7M | 33 | N/A | N/A |
#3 | $7.1M | 33 | 43% | N/A |
#4 | $3.8M | 33 | 38% | N/A |
#5 | $6.6M | 33 | 10% | N/A |
